Jones Paul A.'s Form 4 filing
Usana Health Sciences Inc (USNA) · filed Nov 5, 2021
- Accession no.
- 0001179110-21-009893
- Filed
- Nov 5, 2021
- Trade date
- Nov 3, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $216.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jones Paul A.CIK 0001565541 | Officer (Chief Leadership Dev Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2021 | Common Stock | SSaleDisposed | −2,136 | $101.25F1 | −$216,270 | 5,578 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Weighted average price $101.2488. Price range in multiple transactions was $100.17 to $101.75 inclusively.
Referenced by the price of 1 transaction in Table I.